AXA: UBS still 'neutral' - adjusts target

(CercleFinance.com) - UBS maintains its "neutral" rating on AXA, while inching up its target price to 22 euros (vs.
against 21.5 euros previously), noting that "Investors (are) bearish on key debates ahead of the Investor Day" to be held by the insurance company.

"UBS Evidence Lab survey indicates execution risk & capital deployment are the key debates. Clarity on capital deployment may be insufficient to shift sentiment."

Copyright (c) 2018 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.